[go: up one dir, main page]

RU98109203A - METHOD FOR TREATING VIRAL HEPATITIS B IN CHILDREN - Google Patents

METHOD FOR TREATING VIRAL HEPATITIS B IN CHILDREN

Info

Publication number
RU98109203A
RU98109203A RU98109203/14A RU98109203A RU98109203A RU 98109203 A RU98109203 A RU 98109203A RU 98109203/14 A RU98109203/14 A RU 98109203/14A RU 98109203 A RU98109203 A RU 98109203A RU 98109203 A RU98109203 A RU 98109203A
Authority
RU
Russia
Prior art keywords
children
viral hepatitis
treating viral
hepatitis
patient
Prior art date
Application number
RU98109203/14A
Other languages
Russian (ru)
Other versions
RU2154478C2 (en
Inventor
В.А. Тихонова
Л.Г. Горячева
Н.В. Рогозина
М.Г. Романцов
Original Assignee
Научно-исследовательский институт детских инфекций
Filing date
Publication date
Application filed by Научно-исследовательский институт детских инфекций filed Critical Научно-исследовательский институт детских инфекций
Priority to RU98109203A priority Critical patent/RU2154478C2/en
Priority claimed from RU98109203A external-priority patent/RU2154478C2/en
Publication of RU98109203A publication Critical patent/RU98109203A/en
Application granted granted Critical
Publication of RU2154478C2 publication Critical patent/RU2154478C2/en

Links

Claims (1)

Способ лечения гепатита В у детей путем введения больному индуктора интерферона, отличающийся тем, что больным острым и хроническим вирусным гепатитом В с репликацией вируса назначают внутримышечное введение 12,5% раствора циклоферона в дозе 6 мг на кг массы тела больного по прерывистой схеме в течение 39 дней.A method of treating hepatitis B in children by introducing an interferon inducer to a patient, characterized in that patients with acute and chronic viral hepatitis B with virus replication are prescribed intramuscular injection of 12.5% cycloferon solution at a dose of 6 mg per kg of patient body weight according to an intermittent regimen for 39 days.
RU98109203A 1998-05-19 1998-05-19 Method of treatment of children with viral hepatitis b RU2154478C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98109203A RU2154478C2 (en) 1998-05-19 1998-05-19 Method of treatment of children with viral hepatitis b

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98109203A RU2154478C2 (en) 1998-05-19 1998-05-19 Method of treatment of children with viral hepatitis b

Publications (2)

Publication Number Publication Date
RU98109203A true RU98109203A (en) 2000-02-10
RU2154478C2 RU2154478C2 (en) 2000-08-20

Family

ID=20206001

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98109203A RU2154478C2 (en) 1998-05-19 1998-05-19 Method of treatment of children with viral hepatitis b

Country Status (1)

Country Link
RU (1) RU2154478C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2553179C1 (en) * 2014-03-05 2015-06-10 Федеральное государственное бюджетное учреждение научно-исследовательский институт детских инфекций. Федерального медико-биологического агентства Method of treating chronic hepatitis in children

Similar Documents

Publication Publication Date Title
MY133891A (en) Polyethylene glycol modified interferon therapy
AR021876A1 (en) COMBINATION THERAPY FOR HCV INDUCTION OF RIBAVIRINA - INTERFERON ALFA PEGILADO
DK0858343T3 (en) Continuous low dose cytokine infusion therapy
DE60237721D1 (en) COMBINATION THERAPY WITH OMEGA INTERFERON FOR THE TREATMENT OF HEPATITIS C VIRUS OR YELLOW VIRUS INFECTIONS
MD1875F1 (en) Method of treatment of the acute viral hepatitis B
HK1041215A1 (en) Use of thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir in manufacturing pharmaceutical combination preparations for treating hepatitis b infection.
RU98109203A (en) METHOD FOR TREATING VIRAL HEPATITIS B IN CHILDREN
MY121198A (en) Method of treating hepatitis c in non-responders to interferon treatment.
CY1106388T1 (en) THERAPY OF HEPATITIS C WITH THYMOSIN, INTEPHON, AND RIBAVIRIN
Dalmi et al. Elimination of HBsAg and HBeAg after alpha-interferon treatment
RU99125410A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS
RU2003125593A (en) METHOD FOR TREATING ACUTE VIRAL HEPATITIS IN
RU95114168A (en) A MEANS POSSIBILITY TO PURPOSE ADVERSE EFFECTS OF INTEGRATED AND COMBINED TREATMENT OF MALIGNANT NEW FORMATIONS, TREATMENT OF HEPATITIS, AS VIRUS, AND INDUSTRIATED ALIMOUS ANIMAL
DK1311286T3 (en) Treatment of hepatitis C with thymosin and pegylated interferon
RU99119123A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS
TH53874A3 (en) Combined HCV therapy by induction of ribavirin and pegilate-type interferon alpha.